Vincent currently supports strategic initiatives including overall company strategy, partnerships, media and branding and clinical operations. He has helped lead the clinical operations and media activities for HiFiBiO’s first IND submission for its SARS-CoV-2 neutralizing antibody. Previously, he has worked for a mix of biotech, pharma, and life science strategy consulting. Mr. Tse received his MBA degree from Duke Fuqua School of Business, MS from Northeastern University and Bachelors from UCLA.